US Bancorp’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2K Buy
1,519
+44
+3% +$422 ﹤0.01% 3280
2025
Q4
$17.2K Sell
1,475
-100
-6% -$973 ﹤0.01% 3144
2025
Q3
$15.8K Buy
1,575
+649
+70% +$9.31K ﹤0.01% 3155
2025
Q2
$16.2K Buy
926
+11
+1% +$159 ﹤0.01% 3250
2025
Q1
$11.5K Sell
915
-19
-2% -$229 ﹤0.01% 3390
2024
Q4
$9.85K Sell
934
-17,746
-95% -$249K ﹤0.01% 3419
2024
Q3
$271K Buy
18,680
+18,525
+11,952% +$220K ﹤0.01% 1873
2024
Q2
$1.32K Hold
155
﹤0.01% 3774
2024
Q1
$1.58K Hold
155
﹤0.01% 3759
2023
Q4
$849 Buy
+155
New +$679 ﹤0.01% 3814
2022
Q1
Sell
-1,843
Closed -$12K 4193
2021
Q4
$12K Buy
1,843
+1,597
+649% +$13K ﹤0.01% 3362
2021
Q3
$2K Sell
246
-68
-22% -$1.68K ﹤0.01% 3918
2021
Q2
$10K Buy
314
+266
+554% +$8.53K ﹤0.01% 3403
2021
Q1
$2K Buy
+48
New +$2.27K ﹤0.01% 3731

Other funds holding SPRY